Skip to content
PeptideAgent

Telehealth providers in South Carolina

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in South Carolina. What South Carolina requires of telehealth prescribers and pharmacies, plus verified listings.

South Carolina at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving South Carolina

No verified telehealth providers serving South Carolina are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in South Carolina

Section 40-47-37 of the South Carolina Code sets the rules for physicians practicing solely by telemedicine. The physician must hold a South Carolina medical license, meet the in-person standard of care, verify the patient's identity and location, and provide an appropriate evaluation before treating, which need not be in person if the physician can accurately diagnose and treat through telehealth. At each encounter the prescribing physician must obtain the threshold information needed for an accurate diagnosis in a medical history interview that the prescriber conducts, and a physician may not establish a relationship by telemedicine for prescribing when an in-person physical examination is necessary. Schedule II and III narcotic prescriptions are barred by telemedicine outside narrow exceptions; GLP-1 medicines and the peptides in this database are not scheduled. Because the statute requires a medical history interview conducted by the prescriber, a questionnaire-only asynchronous model does not clearly satisfy it, so this record marks asynchronous prescribing as unresolved. [2] [3]

Compounded GLP-1 access in South Carolina

Telehealth GLP-1 patients should confirm that the prescriber holds a South Carolina license and that any mail order pharmacy holds a South Carolina nonresident permit under section 40-43-83. [3] [5] [10]

Research use only sellers in South Carolina

The South Carolina Pharmacy Practice Act limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so an online seller shipping "research use only" injectable peptides to South Carolina consumers is not operating as a pharmacy under chapter 43. The South Carolina Board of Medical Examiners has also issued a notice that a physician may not compound, administer, prescribe, or dispense research-grade or FDA-ineligible peptides, may not delegate those acts to APRNs or PAs, and cannot rely on a patient consent form. The notice states that facilities inside or outside South Carolina may not sell or dispense drugs without a Board of Pharmacy license (S.C. Code 40-43-83 and 40-43-89), that physicians, APRNs, PAs, and pharmacists must buy all prescription products and compounding ingredients from Board of Pharmacy permitted entities, and that buying from an unpermitted source can be misconduct under S.C. Code 40-47-110(B). [4] [11] [12]

How to check a telehealth provider in South Carolina

  1. Confirm the prescriber is licensed or registered to treat patients located in South Carolina; the telehealth rules above explain what South Carolina requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the South Carolina Board of Pharmacy (South Carolina Department of Labor, Licensing and Regulation) license lookup. [1] [4] [5] [6] [7] [8] [9]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Carolina. [4] [11] [12]

Common questions in South Carolina

Will a South Carolina telehealth doctor prescribe from an online form alone?

It is unlikely to be compliant. Section 40-47-37 requires the prescribing licensee to collect the information needed for an accurate diagnosis in a medical history interview at each encounter, which is hard to satisfy with a static questionnaire. Expect a video or phone visit or a live exchange with the prescriber. [2] [3]

Does an out-of-state pharmacy need a South Carolina permit to mail me compounded peptides?

Yes. Section 40-43-83 requires out-of-state pharmacies that ship or deliver prescription drugs to South Carolina residents to hold a Board of Pharmacy permit, and the Board can refuse a permit it finds is not in the public interest. The Board's non-resident application requires any pharmacy that compounds to document compounding training, submit a diagram and photographs of its compounding areas, and provide environmental and cleaning logs, and its pharmacist-in-charge or permit holder must appear before the Board's Non-Resident Application Review Committee. [1] [5] [7] [8]

All peptide legal questions for South Carolina

Sources

  1. [1]South Carolina Board of Pharmacy (Department of Labor, Licensing and Regulation)
  2. [2]South Carolina Board of Medical Examiners
  3. [3]South Carolina Code section 40-47-37, Practice of telemedicine, requirements (title 40, chapter 47)
  4. [4]South Carolina Code title 40, chapter 43, South Carolina Pharmacy Practice Act
  5. [5]South Carolina Code section 40-43-83, In-state facilities and out-of-state mail order pharmacy service permits
  6. [6]South Carolina Code section 40-43-86, Facility requirements for pharmacies, including compounding
  7. [7]South Carolina Board of Pharmacy: Non-Resident Pharmacy Permit Application, including non-sterile and sterile compounding requirements (revised February 2019)
  8. [8]South Carolina Board of Pharmacy: facility permit types and non-resident application review
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts
  12. [12]South Carolina Board of Medical Examiners: Notice Concerning the Prescribing of Research-Grade Peptides and FDA-Ineligible Peptides